Recce Pharmaceuticals Announces RECCE® Trademark Registered in Vietnam, Strengthening Global IP Portfolio

September 8, 2023

The RECCE® trademark represents a groundbreaking class of synthetic antibiotics developed by Recce Pharmaceuticals. These antibiotics exhibit tremendous potential in combating a wide spectrum of bacterial infections, including the daunting antibiotic-resistant strains that have become a global healthcare challenge.


The registration of the RECCE® trademark in Vietnam signifies a pivotal development in Recce Pharmaceuticals’ global IP strategy. This strategic expansion is aligned with the company’s overarching mission to provide innovative solutions that address the pressing global health crisis posed by antibiotic resistance.


Vietnam, with its burgeoning pharmaceutical sector characterized by rapid growth and development, holds enormous promise for RECCE® and its potential applications. The registration of the trademark not only serves to protect Recce Pharmaceuticals’ valuable IP assets but also opens doors to a myriad of possibilities, including potential collaborations, partnerships, and market opportunities within the Vietnamese pharmaceutical landscape.


Recce Pharmaceuticals remains at the forefront of the battle against antibiotic-resistant bacteria, making strides in developing effective treatments. The registration of the RECCE® trademark in Vietnam is not merely a legal formality but a strategic step with profound implications. It not only reaffirms the company’s commitment to safeguarding its innovations but also positions RECCE® as a potent weapon in the fight against antibiotic-resistant bacteria, both in Vietnam and on the global stage.

Leave a Comment